Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1992-2-28
pubmed:databankReference
pubmed:abstractText
Previous data suggest that structural abnormalities of immunoglobulin light chains may be responsible for non-amyloid light chain deposition disease (LCDD). We report on the complete primary sequence deduced from complementary (c)DNA analysis of a normal-sized kappa chain in a case of myeloma-associated LCDD. The patient's urine contained a kappa type Bence-Jones protein made of monomers and dimers of an unglycosylated kappa chain. The bone marrow myeloma cells contained intracellular kappa and gamma chains by immunofluorescence. Biosynthesis experiments showed the production of normal-sized gamma chains and of kappa chains with the same apparent molecular mass (Mr) in SDS gels as the urinary kappa chain (26,000-27,000). These kappa chains were secreted as assembled IgG molecules and as a large excess of free monomers and dimers. The complete sequence of two identical cDNA clones derived from a normal-sized kappa messenger RNA indicated that this kappa chain belonged to the rare V kappa IV subgroup. The kappa mRNA had an overall normal structure made up of the V kappa IV sequence rearranged to J kappa 1 and followed by a normal constant exon of the Km(3) allotype. The variable region differed from the V kappa IV-J kappa 1 germline sequence by 17 amino acid substitutions. The peculiar sequence of the variable region of this kappa chain of a rare subgroup might relate to its tissue deposition.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-1904072, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-2106817, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-2495723, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-2506646, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-2997712, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-3084147, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-3137264, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-3681981, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-6276389, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-6775818, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-6776810, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-6783355, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-6808027, http://linkedlifedata.com/resource/pubmed/commentcorrection/1733627-814812
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
122-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.
pubmed:affiliation
CNRS URA 1172, Laboratory of Molecular Immunology, Faculté des Sciences, University Hospital, Poitiers, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't